MoonLake Immunotherapeutics

MLTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.344 B

$18.26 +1.28%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$227.3M

Loss-making

Shares outstanding

73,615,396

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#145Xeris BiopharmaXERS$1.37B
#146SchrodingerSDGR$1.36B
#147MoonLake ImmunotherapeuticsMLTX$1.34B
#148MannkindMNKD$1.32B
#149Seaport TherapeuticsSPTX$1.26B

Where these numbers come from

Share counts and financials for MoonLake Immunotherapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.